Saturday, October 31, 2026

Peloton Stock Bullish Momentum With A 10% Rise At Session Start Today

ViaNews Editorial Team

December 22, 2020

Peloton Stock Bullish Momentum With A 10% Rise At Session Start Today

Shares of Peloton rose by a staggering 10.78% to $159.96 at 09:37 EST on Tuesday, after five successive sessions in a row of gains. The Nasdaq Stock Market is falling 0.1% to $12,742.50, after two successive sessions in a row of losses. This seems, as yet, a somewhat negative trend trading session today.

Peloton's last close was $139.84, 10.42% below its 52-week high of $144.87.

News about Peloton today

Stocks making the biggest moves in the premarket: Peloton, sportsman's warehouse, fubotv & more. According to today's article on CNBC, "Peloton (PTON) - Peloton is acquiring rival fitness equipment maker Precor for $420 million, in a deal that will give it more market share as well as increased manufacturing capacity. ", "Peloton shares jumped 9% in premarket trading."

The company's growth estimates for the present quarter and the next is 140% and 115%, respectively.

Peloton's Revenue

Year-on-year quarterly revenue growth grew by 232.4%, now sitting on 2.36B for the twelve trailing months.

Peloton's Stock Yearly Top and Bottom Value

Peloton's stock is valued at $159.96 at 09:37 EST, way higher than its 52-week high of $144.87.

Peloton's Moving Average

Peloton's value is way above its 50-day moving average of $114.37 and way higher than its 200-day moving average of $88.03.

Previous days news about Peloton

Peloton makes biggest purchase with $420 million precor deal. According to Bloomberg Quint on Mon Dec 21, "The deal will also bring about 100 Precor research-and-development engineers to Peloton. ", "Peloton sales have soared this year as the pandemic shut gyms and forced people to work out from home. "

Peloton to buy fitness equipment maker precor in $420 million deal. According to MarketWatch on Mon Dec 21, "S.consumers, Peloton will be able to deliver connected fitness products to members sooner," the company stated in its news release.", "Precor, a division of privately owned sporting-goods company Amer Sports, based in Finland, has an established manufacturing facility in North Carolina, which will help Peloton develop U.S. manufacturing capability. "

Peloton will spend $420 million to acquire precor, known for making fitness equipment found in hotels, health clubs, and university gyms. According to Business Insider on Mon Dec 21, "Peloton stock tumbled 3% after Apple's early December announcement. ", "Peloton sales spiked in 2020 when gyms closed due to the COVID-19 pandemic and more Americans invested in at-home fitness. "

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com